New Blood Test Could Predict Alzheimer&#x27;s Risk but Faces Ethical and Practical Challenges New Primate Species &#x27;Likweli&#x27; Discovered in Congo: Unique Features and Ecological Role Revealed Hillsborough Meteorite: Rare CM1/2 Fall Reveals Prebiotic Secrets and Solar System Origins ISRO Tightens Resignation Rules Amid Scientist Exodus Threatening Key Space Missions Breakthrough Study Reveals MHC-Independent Pathway for T Cell Attack on AML Cells To subscribe visit https://www.brief.news. For more updates in your inbox each morning visit www.brief.news. Image credit: Inside Precision Medicine

Blood Test Predicts Alzheimer's Risk, New Primate Species Likweli Emerges, Hillsborough Meteorite Reveals Origins, ISRO Tightens Rules as Scientists Exit, and more...

Science News Daily

Good morning. It's July 16th, and this is your Daily Brief in Science News Daily. Here's everything you need to know. A new blood test measuring P-tau-217 shows promise for predicting 5-10 year risk of cognitive impairment in symptom-free older adults, raising the possibility of earlier recruitment for Alzheimer's disease prevention trials. The test is not a diagnostic tool and should be used as part of a broader risk assessment that includes lifestyle and metabolic factors.

Several limitations temper enthusiasm, including underrepresented demographics, the need for longer follow-up to stabilize 10-year risk estimates, and current imprecision for individual prognosis. Experts caution that this test should not change existing health guidance or lifestyle recommendations, even as it becomes one element of risk evaluation.

Regulatory and reimbursement hurdles persist, with FDA-cleared tests currently for symptomatic use and Medicare coverage for pre-symptom testing still under evaluation. Quality control issues have affected some tests. There is a call for broader validation across diverse populations and for integrating biomarker tests into a comprehensive diagnostic framework, rather than using them in isolation.

While disease-modifying therapies advance, guidelines still limit testing to diagnostic contexts in specialty care, and biomarkers are increasingly considered in clinical decision-making. Public outreach around brain health and dementia awareness continues, with screenings and discussions illustrating broader efforts beyond the science. The discussion includes policy dimensions in places like Massachusetts, where higher education funding and labor actions form part of the broader public policy landscape.

If validated and ethically deployed, the test could shift risk assessment to primary care, enable earlier personalized interventions, and speed up trial recruitment, while underscoring the need for counseling and equitable access. A newly identified primate species in the Democratic Republic of Congo now bears the name Colobus congoensis, described as an orangish-lipped colobus with a distinctive mask-like face...

Blood Test Predicts Alzheimer's Risk, New Primate Species Likweli Emerges, Hillsborough Meteorite Reveals Origins, ISRO Tightens Rules as Scientists Exit, and more...

Read the full transcript

The candid version is on a podcast,
not the earnings call.

Blood Test Predicts Alzheimer's Risk, New Primate Species Likweli Emerges, Hillsborough Meteorite Reveals Origins, ISRO Tightens Rules as Scientists Exit, and more...

Read the full transcript

The candid version is on a podcast, not the earnings call.

The candid version is on a podcast,
not the earnings call.